dsip peptide sciences for Detox Delta-Sleep-Inducing Peptide (DSIP) – Phoenix

Nausea and Gastrointestinal Discomfort: Nausea is reported by a subset of oral and injectable BPC-157 users in community-level accounts, particularly at doses above 500 mcg per day

It is not a drug, food, supplement, or cosmetic, is not approved by the FDA, and is not intended to diagnose, treat, cure, or prevent any disease, or for human or veterinary consumption

Human data is still limited, so it is best seen as promising rather than proven and used only under a physician's guidance

If you are concerned about how you are feeling, contact our team for a clinical review before making any changes to your treatment

Chronic insomnia sometimes benefits from cognitive behavioral therapy for insomnia (CBT-I), a structured approach that addresses thought patterns and behaviors perpetuating sleep difficulties